Filing Details
- Accession Number:
- 0001209191-21-051759
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-17 09:11:24
- Reporting Period:
- 2021-08-16
- Accepted Time:
- 2021-08-17 09:11:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1533040 | Phio Pharmaceuticals Corp. | PHIO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1704417 | Gerrit Dispersyn | C/O Phio Pharmaceuticals Corp. 257 Simarano Drive, Suite 101 Marlborough MA 01752 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.0001 Par Value | Acquisiton | 2021-08-16 | 6,000 | $1.63 | 95,281 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Includes shares of common stock underlying unvested restricted stock units.